Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality

H W Zimmermann, P A Reuken, A Koch, M Bartneck, C Trautwein, A Stallmach, F Tacke, T Bruns, David Adams

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

Patients with decompensated cirrhosis are susceptible to bacterial infections, which are associated with organ failure and a high mortality rate. Reliable biomarkers are needed to identify patients who require intensified treatment. Our objective was to study the regulation and prognostic relevance of elevated concentrations of soluble urokinase plasminogen activator receptor (suPAR) in patients with advanced cirrhosis.
Original languageEnglish
Pages (from-to)86-100
Number of pages15
JournalJournal of Internal Medicine
Volume274
Issue number1
DOIs
Publication statusPublished - Jul 2013

Bibliographical note

© 2013 The Association for the Publication of the Journal of Internal Medicine.

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Ascitic Fluid
  • Bacterial Infections
  • Biological Markers
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Escherichia coli Infections
  • Female
  • Germany
  • Humans
  • Liver
  • Liver Cirrhosis
  • Male
  • Middle Aged
  • Odds Ratio
  • Paracentesis
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Receptors, Urokinase Plasminogen Activator
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index

Fingerprint

Dive into the research topics of 'Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality'. Together they form a unique fingerprint.

Cite this